Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
Blind Multicenter Study of the Efficacy and Safety of Injections of a Commercial Preparation of Botulinum Toxin Type A Reconstituted up to 15 Days Before Injection
Dermatologic Surgery, 06/18/09
Hexsel D et al. - The results confirm the possibility of injecting 500 U of BT-A up to 15 days after its reconstitution safely and without loss of efficacy.
Related Articles
Supraciliary wrinkles and botulinum toxin A
Clinical and Experimental Dermatology, 11/16/09
Relevance Score: 68%
Botulinum toxin in the treatment of lingual movement disorders
Movement Disorders, 10/06/09
Relevance Score: 68%
Comparison of Pain Scores With 30-Gauge and 32-Gauge Needles for Periocular Botulinum Toxin Type A Injections
Ophthalmic Plastic and Reconstructive Surgery, 10/05/09
Relevance Score: 68%
Treatment of a Painful Keloid with Botulinum Toxin Type A
American Journal of Physical Medicine & Rehabilitation, 11/05/09
Relevance Score: 67%
Botulinum toxin: An emerging therapy in female bladder outlet obstruction
Indian Journal of Urology, 10/02/09
Relevance Score: 67%
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Idiopathic Chilblains
American Journal of Medicine, 12/10/09
New insights into pigmentary pathways and skin cancer
British Journal of Dermatology, 12/10/09
The 5-D itch scale: a new measure of pruritus
British Journal of Dermatology, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


